throbber
Low-concentration Homogenized Castor Oil
`Eye Drops for Noninflamed Obstructive
`Meibomian Gland Dysfunction
`
`Eiki Goto MD12 Jun Shimazaki MD1 Yu Monden MD3 Yoji Takano MD12 Yukiko Yagi1
`Shigeto Shimmura MD12 Kazuo Tsubota MD12
`
`Objective
`
`trial
`
`We developed low-concentration
`homogenized castor oil eye drops for the treatment of patients
`with noninflamed obstructive meibomian gland dysfunction MGD major cause of lipid-deficiency dry eye and
`assessed the safety stability and efficacy of the eye drops
`Design Randomized double-masked placebo-control
`led crossover clinical
`Forty eyes of 20 patients with noninflamed MGD
`Participants
`preliminary study of eye drops containing castor oil 2% castor oil and 5% polyoxyethylene
`Methods After
`castor oil emulsifier were mixed to formulate homogenized oil eye drops The patients were assigned randomly
`weeks each
`to receive oil eye drops or placebo six times daily for
`periods of
`Main Outcome Measures At the end of each treatment period we assessed symptoms tear interference
`grade tear evaporation fluorescein and rose bengal scores tear break-up time BUT and meibomian gland
`orifice obstruction Safety and stability tests were also performed
`Results Symptom scores tear
`interference grade tear evaporation test results rose bengal scores tear
`BUT and orifice obstruction scores after the oil eye drop period showed significant
`improvement compared with
`the results after the placebo period No complications attributable to the eye drops were observed The oil eye
`drops were stable when stored at 4C
`The results indicate that castor oil eye drops are effective and safe in the treatment of MGD
`Conclusions
`The possible mechanisms of this treatment are improvement of tear stability as
`lipid spreading ease
`of meibum expression
`evaporation and
`the
`effect
`of
`the oil
`of
`tear
`eye
`lubricating
`prevention
`
`drops Ophthalmology2002 2002 by the American Academy of Ophthalmology Inc
`
`result of
`
`lipids into tears and the lipids
`Meibomian glands secrete
`expand to form the oily preocular
`film layer that
`tear
`excessive evaporation of
`isponsible for preventing
`tears
`barrier function at
`while also providing
`the lid margin
`lubrication during blinking and producing
`smooth optical
`1-5 Noninflamed obstructive meibomian gland dys
`surface
`function MGD is the major cause of lipid tear deficiency
`or evaporative dry eye and recently has attracted attention as
`
`is
`
`Originally received October 29 2001
`Accepted March 22 2002
`
`Manuscript no 210908
`
`Department of Ophthalmology Tokyo Dental College Chiba Japan
`
`Department of Ophthalmology Keio University School of Medicine
`Tokyo Japan
`
`Department of Ophthalmology Kurume University School of Medicine
`Kurume Japan
`
`and Science
`Supported by grants from the Japanese Ministry of Education
`Tokyo Japan Medical School Faculty and Alumni Grants of Keio Uni
`versity Medical Science Fund Tokyo Japan Hightech Research Center at
`Tokyo Dental College Chiba Japan and Nihon Tenganyaku
`Kenkyusho
`Co Ltd Nagoya Japan
`Authors Eiki Goto MD Kazuo Tsubota MD and Nihon Tenganyaku
`Kenkyusho Co Ltd are in the process of obtaining
`Japanese patent on
`herein and their clinical application
`the eye drops described
`requests to Kazuo Tsubota MD Department
`and reprint
`Correspondence
`of Ophthalmology
`Tokyo Dental College 5-1 1-13 Sugano
`Chiba Japan 272-8513 E-mail eikigoto@nifty.com
`
`Ichikawa-shi
`
`cause of ocular discomfort.68 Meibomian gland dysfunc
`decreased lipid supply which in turn leads to
`tion causes
`increased tear evaporation decreased tear stability loss of
`lubrication and damage to ocular surface epithelium result
`ing in symptoms ilated to dry eye.79 The conventional
`for blepharitis and MGD includes warm com
`treatment
`lid hygiene and topical or systemic medica
`presses
`tion.52 Nevertheless
`long-term compliance with con
`is often insufficient and thus results in
`ventional
`therapy
`only limited relief of symptoms Another possible approach
`is direct supplementation with oil as the deficient compo
`nent Lipid-containing eye drops designed to simulate nat
`ural tears previously have been reported to be an effective
`they have not been accepted
`treatment
`for dry eye but
`generally.34 Because high-concentration
`oil eye drops and
`ointments are viscous and cause blurred vision resulting in
`decreased patient satisfaction we conducted
`preliminary
`low-concentration
`assessment of the efficacy of
`castor oil
`mixture and in this study assessed the efficacy safety and
`stability of low-concentration
`and homogenized oil eye drops
`
`Materials and Methods
`
`Preliminary Study to Choose Oil
`We used seven oil
`ingredients permitted as additives for eye drops
`low-concentration mixture
`and ointments in Japan to fomrnlate
`
`2030
`
`2002 by the American Academy of Ophthalmology
`Inc
`
`Published by Elsevier Science
`
`Inc
`
`ISSN 0161-6420/02/Ssee front matter
`
`PIT S0161-64200201262-9
`
`FAMY CARE - EXHIBIT 1017-0001
`
`

`
`Goto et
`
`Castor Oil Eye Drops for MOD
`
`Results of Preliminary Study using Castor Oil Mixture
`Table
`for Noninflamed Obstructive Meibomian Gland Dysfunction
`Mean
`Standard Deviation
`
`Examination
`
`Before
`
`Aftert
`
`Value
`
`Pace score 19
`
`Tear evaporation rates
`X107 g/second
`score 09
`Pluorescein
`Rose bengal score 09
`
`time
`
`Tear break-up
`sec
`Schirmers test value mm
`
`7.5
`
`1.6
`
`309.0
`
`1.6
`
`1.2
`
`1.5
`
`1.4
`
`3.4
`
`2.4
`
`5.3
`
`14
`2211
`
`0.20
`
`o.so
`
`9.0
`
`060
`0.76
`
`36
`
`1814
`
`1612
`
`0.01
`
`0.02
`
`0.005
`
`0.2
`
`0.002
`
`0.6
`
`by Wilcoxons
`signed rank test
`Data were analyzed
`value of 005 was accepted
`paired data
`Result before use of castor oil mixture
`Result after
`weeks of application of castor oil mixture
`Statistically significant
`
`for nonparametric
`
`as statistically significant
`
`artificial
`
`tears Soft Santear Santen Phar
`with preservative-free
`maceutical Co Ltd Osaka Japan and tested them on normal and
`dry eye volunteers.15 Because the subjects reported that
`the castor
`oil Astra Japan Osaka Japan mixture eye drops were the most
`comfortable this mixture was formulated for use in
`preliminary
`trial and applied to MGD patients
`weeks The
`times daily for
`surface and tear
`function were examined and compared
`before and after application The examinations are described in
`later section As shown in Table
`score tear break-up time BUT and tear evaporation
`fluorescein
`rates improved significantly The mixture was simple to formulate
`but being made from only hydrophobic oil
`it may not spread
`the ocular surface We therefore decided to formulate
`readily over
`oil eye drops with castor oil
`
`ocular
`
`detail
`
`in
`
`the face score
`
`homogenized
`
`Formulation Safety and Stability of Low-
`concentration Homogenized Oil Eye Drops
`
`tion of castor oil
`
`To formulate low-concentration and homogenized oil eye drops
`oil eye drops 2% castor oil
`lubricant castor oil Yoshida Phar
`maceutical Co Tokyo Japan 5% polyoxyethylene castor oil
`Sigma St Louis MO 0.3% sodium
`POE castor oil
`chloride 0.15% potassium chloride and 0.5% boric acid were
`stirred into distilled water under sterile conditions The concentra
`in the preliminary study was changed to formulate
`of the eye drops were lucent
`an emulsion The characteristics
`odorless and low viscosity The pH of the eye drops was 7.0 and
`their osmolarity was 260 mOsmlkg H20 Bacterial and fungal
`cultures of the remaining unused eye drops were performed at the
`the usual conditions at room temperature.16
`end of therapy under
`The stability of the eye drops was assessed by testing for
`weeks
`at 60C and 4C Stress testing testing at 60C for weeks was
`testing at 40C for
`performed instead of accelerated
`testing
`months for the eye drops.17 In these tests the pH of the eye drops
`was measured and the volunteers were checked for any irritation
`that might have been caused by administering the eye drops The
`samples stored at 4C remained stable at pH 7.0 for
`weeks and
`did not cause irritation whereas the pH value of the samples stored
`at 60C changed to 5.8 and caused irritation
`
`Subjects
`
`We examined
`series of 20 patients 40 eyes with
`MGD whose symptoms had not
`improved sufficiently despite
`
`consecutive
`
`conventional
`
`treatment such as by lid hygiene and topical therapy
`with artificial
`and corticosteroids or systemic
`tears antibiotics
`antibiotics Both eyes of patients were included The participants
`males and 13 females 52.1
`11.0 years with
`consisted of
`MGD Nine patients had Schirmers test value of less than mm
`indicating aqueous tear deficiency.918 Four patients of the aqueous
`group were diagnosed with Sjogrens syndrome
`tear deficiency
`according to aqueous tear deficiency.19 Eyes with anterior bleph
`antis of more than moderate
`severity infectious conjunctivitis
`MGD with acute inflammation and eyes with excessive expression
`of meibum seborrheic MGD were excluded
`from the study No
`patients used contact
`
`lenses
`
`Criteria for Meibomian Gland Dysfunction
`Criteria for the diagnosis of MGD were presence of meibomian
`gland dropout poor meibum expression and lack of active inflam
`mation.79 Transillumination examination meibography with
`fiber-optic device L-3920 Inami Co Tokyo Japan was per
`formed.20 Visible loss of meibomian gland structure gland drop
`out was observed during meibography and was considered evi
`dence of MGD because this finding was reported to be
`good
`The
`for MGD-associated ocular surface
`changes.79
`parameter
`degree of meibomian gland dropout was
`scored as described
`no gland dropout grade
`previously7-9 grade
`less than half of the inferior
`tarsus and grade
`more than half of the inferior
`tarsus
`To assess meibum expression
`and meibomian gland orifice
`obstruction digital pressure was applied on the upper
`tarsus and
`of meibomian secretions
`ease of expression
`the degree
`of
`meibum was evaluated semiquantitatively as follows grade
`clear meibum easily expressed grade
`cloudy meibum expressed
`cloudy meibum expressed with more
`with mild pressure grade
`meibum could not be ex
`than moderate pressure and grade
`pressed even with strong pressure.79 Patients with meibography
`score of grade
`and meibomian gland orifice obstruction
`or
`or were diagnosed as having MGD in this study
`score of
`
`gland dropout
`
`in
`
`gland dropout in
`
`Assessment of Symptoms Tears Ocular Surface
`and Meibomian Glands
`
`on overall comfort complaints and complications
`questionnaire
`face score card that showed nine
`was administered by using
`different expression.16 For example the saddest
`faces each with
`described severe symptoms and irritation of the
`face scored as
`ocular surface and the happiest
`represented no
`face scored as
`irritation of the ocular surface This face score was used to assess
`patient sensation of lubrication and smoothness during blinking in
`
`this study
`images were assessed using DR-i camera
`Tear
`interference
`Kowa Ltd Nagoya Japan at
`12 magnification based on the
`gray color uni
`somewhat
`grading previously reported grade
`form distribution grade
`somewhat gray color nonuniform dis
`few colors nonuniform distribution grade
`tribution grade
`many colors nonuniform distribution
`grade
`corneal
`surface
`partially exposed.2122 Tear evaporation
`during normal blinking
`was measured by the method previously reported.23 The evapora
`tion rate at 40% ambient humidity was used as
`representative
`value
`
`the double
`
`The ocular
`surface was examined
`by
`method
`2-jtl volume of preservative-free
`solution consisting of
`and 1% rose bengal dye was applied to the con
`1% fluorescein
`sac The intensity of the rose bengal
`the
`staining of
`junctival
`cornea and conjunctiva was recorded with maximum score of
`Tear
`Fluorescein staining of the cornea was also rated from to
`BUT was measured three times and the measurements were av
`
`staining
`
`2031
`
`FAMY CARE - EXHIBIT 1017-0002
`
`

`
`Ophthalmology
`
`Volume 109 Number 11 November 2002
`
`Table
`
`Schedule of Examinations in Crossover Study of Castor Oil Eye Drops for Noninflamed Obstructive Meibomian Gland
`Dysfunction
`
`Week
`
`Group
`Group
`
`Wash-out Period Began
`AT
`AT
`
`Beginning of Study
`Oil eye drop usage began
`Placebot
`usage began
`
`Patients Switched Eye Drops
`Switched to placebot
`to oil eye drops
`Switched
`
`Completion of Study
`Completed
`Completed
`
`AT
`preservative-free
`Low-concentration homogenized
`Placebo eye drops
`controller YY Participants used AT for
`and
`weeks during the washout period used oil eye drops or placebo
`were divided randomly by
`weeks Examinations were performed at
`the end of each 2-week period of treatment
`and then switched
`eye drops for the next
`
`artificial
`
`tear
`
`castor oil eye drops
`
`Groups
`weeks
`
`for
`
`eraged.24 Schirmers test was performed to measure tear secre
`tion.1825 Assessment of meibum expression and meibomian gland
`orifice obstruction was recorded as described above in the inclu
`
`sion criteria section.79
`
`Study Design
`
`artificial
`
`double-blind
`prospective
`randomized
`placebo-controlled
`2-week wash-out
`crossover clinical study was performed after
`tears Soft Santear.26 Dur
`period with preservative-free
`periods of
`weeks each
`the patients were assigned
`ing the
`randomly to receive oil eye drops or placebo eye drops six times
`We used normal saline solution as the placebo eye
`daily Table
`drops At the end of each treatment period i.e the oil eye drop
`period and the placebo period the following examinations de
`scribed below were performed
`The examinations were carried out
`in the following order to
`avoid the influence of one procedure
`on another subjective
`grading DR-i 22 tear
`tear
`interference
`evaporation
`scores16
`test23 fluorescein and rose bengal vital staining BUT measurement
`and assessment of meibomian gland orifice obstruction.79162425
`When the results of the oil eye drop period were better
`than those
`of the placebo period the use of the oil eye drops was judged an
`test was not performed during the study
`improvement Schirmer
`period to avoid any influence on the tear evaporation test which is
`sensitive to ocular surface damage Informed consent was obtained
`from all subjects Institutional Review Board or Ethics Committee
`approval was not required for this study
`
`face
`
`Statistical Analysis
`
`standard deviation Both eyes of
`All data are presented as means
`each patient were studied separately Symptoms and findings at the
`end of each
`treatment period the oil eye drop period and the
`and analyzed
`by Wilcoxons
`placebo period were
`compared
`signed rank test
`paired data
`for nonparametric
`value of less
`than 0.05 was accepted as statistically
`
`significant
`
`Results
`
`Figures
`
`show results
`and
`case with tear
`from representative
`images tear break-up and rose bengal staining at the
`interference
`end of the placebo period Fig
`and at
`the end of oil eye drop
`period Fig
`Each result shows improvement
`from the oil eye
`drop period compared with the placebo period
`The results at the end of placebo period and oil eye drop period
`Compared with the placebo period the
`are shown in Table
`
`2032
`
`subjective
`
`6.7
`
`of the other
`
`0.7i
`
`to 2.0
`
`0.77
`
`face score improved during the oil eye drop period from
`0.004 along with the improvement
`i.6 to 5.5
`i.8
`grade decreased
`tear examinations Tear interference
`0.000i
`from 3.i
`rates
`tear evaporation
`during normal blinking decreased from
`g/second
`6.2
`7.5 i07 g/second
`0.Oi and tear BUT was
`to ii
`2.8 seconds to i2
`seconds
`prolonged from 4.6
`3.5
`score also was ac
`0.000
`The improvement of the subjective
`by improvements of the rose bengal
`companied
`score
`staining
`from 2.2
`0.007 and the meibomian
`i.3
`0.85 to i.4
`gland orifice obstruction score from 2.2
`0.63
`0.38 to i.6
`0.002 but not accompanied
`by the improvement of the fluo
`rescein staining score from 0.4
`0.06
`0.33
`0.8i
`to 0.i3
`the MGD without
`Results of these improvements between
`ii and the MGD with aqueous
`aqueous tear deficiency
`showed no statistically
`group
`tear deficiency
`significant
`difference Administration of the oil eye drops was well tolerated and
`none of the subjects reported initation or severe bluning None of the
`samples tested positive
`for bacteria or
`collected
`ilingi Blinding
`persons perfomuing the intervention outcome
`among participants
`assessors and data analyses were perfomied entirely by protocol
`
`group
`
`Discussion
`
`clear benefit of using low-con
`This study demonstrated
`centration homogenized
`oil eye drops for the treatment of
`MGD Because MGD is major cause of ocular
`irritation
`symptomatic relief is an essential aspect of treatment The
`improvement in symptoms was accompanied by improve
`findings including tear interference im
`ment of objective
`age tear evaporation tear BUT rose bengal staining and
`meibomian gland orifice obstruction The improvements
`were attributed to the effects of the oil eye drops because all
`double-blind protocol The eye
`patients used eye drops in
`drops were stable and well tolerated and they did not cause
`irritation or blurred vision at room temperature By using
`oil we succeeded
`in avoiding the usual
`low-concentration
`of oil administration such as blurred vision
`complications
`and
`viscous sensation
`the missing tear lipid in MGD we used
`To supplement
`POE castor oil
`to solubilize the castor oil
`in distilled water
`low concentration.27 It has been reported that
`hydro
`in
`philic lipid is requiitd to enable oil
`to spread over
`the
`human tear aqueous layer and that polar phospholipids exist
`hydrophilic lipid in tears.2427 The POE castor oil
`as
`derivative of castor oil
`polar lipid having
`hydrophilic
`
`is
`
`FAMY CARE - EXHIBIT 1017-0003
`
`

`
`Cow et
`
`Castor Oil Eye Drops for MCD
`
`Figure
`
`of the representatsve
`interference smage shows
`
`Tear interference image tear break.up and rose bengal staining
`The tear
`the end of the placebo period
`few colors and
`nonunsform pattern
`
`case at
`
`stained by fluoresceiss and rose bengal were taken
`Slit-lamp photographs
`immediately afrer eye opening Note tlse remarkable tear break-up
`and
`bssure Cl
`rose bengal staining of the ocular surface between the palpebral
`
`and
`
`hydrophobic group which is considered to be au ideal
`tears Because the castor oil cau spread over
`oil for artificial
`is expected to make the tear more
`the ocular
`surface it
`stable to decrease tear evaporation and to decrease
`between the lid and ocular surface.28
`
`friction
`
`Tear inrerference image rear brcak up and rose bengal srairilng
`Figure
`The rear
`of rhe same case as in Figure
`at rhe end of oil eyedrop period
`somewhar
`
`Interference
`
`shows
`
`gray color and more uniform distribution
`
`and rose bengal were
`srained by fluorescein
`Slsr.lamp phorographs
`he seen and
`raken immediarely afrer eye opening Tear breale.up cannot
`lB and 2B were enhanccd
`rose bengal staining was decreascd
`Figures
`using Adobe Photoshop Adobe Systems
`digitally to show tear break.up
`lssc San Jose CA from original photographs
`at brightness 40 and
`70 The reflex from the central cornea is the result of rhe digital
`
`contrast
`
`enhancensent
`
`2033
`
`FAMY CARE - EXHIBIT 1017-0004
`
`

`
`Ophthalmology
`
`Volume 109 Number 11 November 2002
`
`Table
`Results of Crossover Study during Placebo and Oil Eye
`Drop Periods for the Treatment of Noninflamed Obstructive
`Meibomian Gland Dysfunction Mean
`Standard Deviation
`
`Examination
`
`Pace score 19
`grading 15
`
`interference
`
`Tear
`
`Tear evaporation
`rates X107
`g/second
`
`Placebo
`Period
`
`6.7
`
`3.1
`
`1.6
`
`0.71
`
`Oil Eye
`Drop Periodt
`
`Valuet
`
`077
`
`13
`
`6.2
`
`11
`
`o.oi
`
`oil
`
`the ideal
`
`considered more for
`eye drops should be
`patients with aqueous tear
`tears Theoretically
`artificial
`from the application of these artificial
`deficiency can benefit
`tears because MGD needs
`to be supplemented by oil or
`some other
`ingredient that can stabilize the ocular surface
`decrease tear evaporation and decrease
`friction between the
`lid and ocular surface Based on study it
`is necessary to
`means of maintaining the stability of artificial
`in rooms with higher temperatures
`tears with castor oil
`however this randomized double-blind study clearly shows
`the benefit of the addition of castor oil
`tears
`to artificial
`
`develop
`
`Rose bengal
`
`Pluorescein
`
`score
`
`09
`score 09
`BUT sec
`
`Orifice
`
`obstruction
`
`03
`
`0.40
`
`0.81
`
`0.13
`
`0.33
`
`0.06
`
`2.2
`
`0.85
`
`1.4
`
`1.3
`
`0.007
`
`References
`
`4.6
`
`2.8
`
`2.2
`
`0.38
`
`12
`
`1.6
`
`3.9
`0.63
`
`0.0001
`
`0.002
`
`Mishima
`
`evaporation
`
`Maurice DM The oily layer of the tear film and
`surface Exp Eye Res 1961
`from the comeal
`
`film physiology Am Optom Physiol Opt
`
`time
`
`BUT tear break-up
`Placebo eye drops
`Low-concentration homogenized
`castor oil eye drops
`by Wilcoxons
`signed rank test
`Data were analyzed
`paired data
`value was determined between
`placebo
`value of 005 was statistically significant
`
`period
`
`Statistically significant
`Meibomian gland orifice obstruction score
`
`for nonparametric
`and oil eye drop
`
`3945
`Holly FJ Tear
`980572527
`Tiffany SM The role of meibomian secretion in the tears
`1985104396401
`Trans Ophthalmol Soc
`Tiffany JIM The lipid secretion of the meibomian glands Adv
`Lipid Res 198722162
`Driver PJ Lemp MA Meibomian gland dysfunction Surv
`9964034367
`Ophthalmol
`Lemp MA Report of
`the National Eye Institute/Industry
`on Clinical Trials in Dry Eyes CLAO 199521
`Workshop
`22 132
`Shimazaki
`Sakata
`Tsubota
`Ocular surface changes
`and discomfort in patients with meibomian gland dysfunction
`Arch Ophthalmol 1995113126670
`Lee SH Tseng SCG Rose bengal
`and cytologic
`associated with lipid tear deficiency Am
`997124736 50
`Ophthalmol
`Ono
`et al Meibomian gland dys
`Shimazaki
`Goto
`function in patients with Sjogren syndrome Ophthalmology
`199810514858
`10 Key JE
`study of eyelid cleaning regimens in
`comparative
`chronic blepharitis CLAO
`19962220912
`11 Korb DR Greiner JV Increase in tear film lipid layer thick
`ness following treatment of meibomian gland dysfunction In
`Sullivan DA ed Lacrimal Gland Tear Film and Dry Eye
`Syndromes New York Plenum Press 19942938
`12 Smith RE Flowers CW Jr Chronic blepharitis
`CLAO
`1995212007
`13 Rieger
`Lipid-containing eye drops
`step closer
`99020 120612
`tears Ophthalmologica
`14 Tiffany JIM Lipid-containing eye drops
`logica 1991203479
`15 Japanese Pharmaceutical
`Nippo 1994 109
`16 Tsubota
`Goto
`et al Treatment of dry eye by
`Fujita
`serum application in Sjogrens syndrome Br
`autologous
`Ophthalmol 1999833905
`17 Awata
`Stability of The Eye Drops In Ohashi
`Eye Drops Tokyo Medical View Co 19961523
`18 Xu KP Yagi
`Toda
`Tsubota
`Tear
`function index
`new measure of dry eye Arch Ophthalmol 1995113848
`19 Fox RI Robinson CA Curd JG et al Sjogrens syndrome
`Proposed criteria for classification Arthritis Rheum 98629
`577 85
`20 Robin JE Jester JV Nobe
`et al In vivo transillumination
`biomicroscopy and photography of meibomian gland dysfunc
`clinical study Ophthalmology 19859214236
`tion
`
`characteristics
`
`staining
`
`review
`
`to natural
`
`Ophthalmo
`
`Excipients
`
`1993 Tokyo Yakuji
`
`ed The
`
`interference
`
`great
`
`it
`
`Both castor oil and POE castor oil are commercially
`available are inexpensive and have been proven to have
`minimal topical toxicity for the eye.528
`It was surprising to us that only minimal amount of
`castor oil changed the ocular
`surface abnormality
`there was evidence
`deal Moreover
`tears over
`that
`the
`ocular surface were stabilized based on the improved tear
`tear BUT The tear
`image and increase of
`interference
`pattern significantly showed
`more uniform
`pattern of spreading of the lipid film layer after administra
`tion of the castor oil eye drops than with administration of
`Even though the amount of castor oil was
`the placebo.2122
`the oil eye drops were well homogenized
`minimal
`in the
`tear lipid layer and later spread to form more stable tear
`lipid layer and to improve the ocular surface condition
`Figs 1A and 2A.212229
`There is
`concern for the clinical application of castor
`oil eye drops because of their limited shelf life stability.7 It
`is expected that oil quality may change during storage room
`temperature and may be an obstacle for clinical application
`When we stored the castor oil at 4C for
`weeks
`the oil
`stability and was well preserved Moreover
`maintained
`did not cause any irritation to the volunteers However after
`storage of the castor oil eye drops at 60C for weeks
`the
`ph changed to 5.8 and caused slight irritation to the patients
`Castor oil
`treatment
`for ocular
`itself
`very effective
`the storage method should be consid
`surface diseases but
`ered before broad clinical application because of the insta
`bility of the oil at higher temperatums
`In conclusion we have documented
`castor oil for the treatment of ocular surface disorders with
`
`is
`
`MGD Although the concept of administering oily eye drops
`has not been considered seriously the application of castor
`
`beneficial effect of
`
`2034
`
`FAMY CARE - EXHIBIT 1017-0005
`
`

`
`Goto et
`
`Castor Oil Eye Drops for MOD
`
`21 Yokoi
`
`layer interference
`
`Takehisa
`Kinoshita
`patterns with the diagnosis
`
`Correlation of tear
`
`lipid
`and severity of
`
`dry eye Am Ophthalmol 1996
`
`Tiffany JIIVI Bron AJ Assessment of
`Mossa
`22 Yokoi
`meibomian gland function in dry eye using meibometry Arch
`Ophthalmol 1999 177239
`23 Tsubota
`Yamada
`Tear evaporation
`
`from the ocular
`
`surface
`24 Toda
`
`Tsubota
`
`Practical
`
`double vital staining
`
`for ocular
`
`surface evaluation
`
`25 van Bijsterveld OP Diagnostic
`
`tests in the sicca syndrome
`
`Invest Ophthalmol Vis Sci 1992
`Cornea 1993
`Arch Ophthalmol 1969
`
`26 Rub AH Greve EL Geijssen HC Hoyng PFJ Reduction of
`intraocular pressure with treatment of latanoprost once daily in
`patients with normal-pressure glaucoma Ophthalmology
`1996 127682
`27 Mitsui
`Physiochemistry of the Cosmetics 1st ed Tokyo
`Nanzando 1993 12856
`28 Nagai
`Polyoxyethylene castor oil derivatives
`ed Handbook of Pharmaceutical Excipients
`Japanese
`The Pharmaceutical Society of Japan
`Edition Tokyo
`
`In Saito
`
`986
`29 Korb DR Baron DF Herman JP et al Tear film lipid layer
`function of blinking Cornea 1994
`
`thickness
`
`as
`
`2035
`
`FAMY CARE - EXHIBIT 1017-0006

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket